about
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis'Micro-managers' of hepatic lipid metabolism and NAFLDExploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease.
P2860
Q26768588-AEA27880-A18A-4268-A9B1-F0729877D3D1Q26801228-CB159D3B-75A9-418C-8B29-4DB44FDEBFC8Q33648066-BA70FCA1-400A-4DDF-82F0-38E2F340996FQ38724173-6BCA263F-02EB-4323-8D95-6B20FBDA66ADQ38752448-6C98E127-8464-4238-9EC8-6F1FC9D6FBC5Q38954546-EDAFA9CF-EAF4-4785-A8B8-E9A94CBE4302Q48101786-DA6E7F48-1B9D-4E39-B6BE-951D8FBEE9E2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs in Liver Disease: Bench to Bedside.
@en
MicroRNAs in Liver Disease: Bench to Bedside.
@nl
type
label
MicroRNAs in Liver Disease: Bench to Bedside.
@en
MicroRNAs in Liver Disease: Bench to Bedside.
@nl
prefLabel
MicroRNAs in Liver Disease: Bench to Bedside.
@en
MicroRNAs in Liver Disease: Bench to Bedside.
@nl
P2093
P2860
P1476
MicroRNAs in Liver Disease: Bench to Bedside.
@en
P2093
James E Nelson
Kris V Kowdley
Nihar Shah
P2860
P304
P356
10.1016/J.JCEH.2013.09.001
P577
2013-09-17T00:00:00Z